Anzeige
Mehr »
Login
Samstag, 20.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire
384 Leser
Artikel bewerten:
(1)

Nasdaq Nordic: Nasdaq Stockholm welcomes SpectraCure to Nasdaq First North Premier Growth Market

Stockholm, October 10, 2019 - Nasdaq (Nasdaq: NDAQ) announces that the trading
in SpectraCure AB's shares (short name: SPEC) will commence today on the Nasdaq
First North Premier Growth Market in Stockholm. SpectraCure belongs to the
health care sector and was previously listed on Nasdaq First North Growth
Market. 

SpectraCure is focused on cancer treatment with medical devices containing
laser light sources and photo reactive drugs, called interstitial photodynamic
tumor treatment (PDT). The treatment methodology is suitable for internal solid
tumors of various kinds, including prostate and pancreas, but also in other
indications such as head and neck cancer. SpectraCure was founded in 2003 and
is headquartered in Lund, Sweden. 

"The fact that we are able to switch to the Premier segment is an important
strategic step in our desire to facilitate institutional and international
ownership of SpectraCure," said Masoud Khayyami, CEO of SepctraCure. "The
Premier segment is targeting companies that are preparing for a main market
listing, with higher disclosure and accounting standards than the regular
Nasdaq First North Growth Market rules. The rules on the Premier segment
corresponds very much to the rules of Nasdaq's regulated main market. This
suits our plans well." 

"We welcome SpectraCure to the Premier segment of Nasdaq First North Growth
Market," said Adam Kostyál, SVP and Head of European Listings, Nasdaq. "We
congratulate SpectraCure on its successful switch and look forward to
supporting the company on its continued growth journey." 

SpectraCure AB has G&W Fondkommission as its Certified Adviser.



About Nasdaq First North Growth Market

Nasdaq First North Growth Market is a registered SME growth market, as defined
by the Directive on Markets in Financial Instruments (EU 2014/65). It does not
have the legal status as an EU-regulated market. Listed companies are subject
to the rules of Nasdaq First North Growth Market and not the legal requirements
for admission to trading on a regulated market, such as the Nasdaq Nordic Main
Market. The risk in such an investment may be higher than on the main market. 

The Premier segment within Nasdaq First North Growth Market is designed to
further assist companies in raising investor visibility and to prepare them for
a Main Market listing. The Premier segment targets companies that make a
conscious decision to comply with higher disclosure and accounting standards
than imposed under the Nasdaq First North Growth Market rules. 

About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing,
exchange technology, listing, information and public company services. Through
its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven technologies
that provide transparency and insight for navigating today's global capital
markets. As the creator of the world's first electronic stock market, its
technology powers more than 100 marketplaces in 50 countries. Nasdaq is home to
over 4,000 total listings with a market value of approximately $14 trillion. To
learn more, visit business.nasdaq.com. 



Nasdaq Media Contact

Erik Granström

+46 73 449 78 07

erik.granstrom@nasdaq.com
Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2019 GlobeNewswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.